Physician Assistant, Surgical · Hartford, CT
NPI
1790132066
Since 2016
Specialty
Physician Assistant, Surgical
Code 363AS0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
114 Woodland St
Hartford, CT, 06105
Phone (860) 714-7708
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
2,691 services
Medicare patients, 2024
251
Average age 69
Drug cost, 2024
$1.1M
10,720 prescriptions
Company payments, 2025
$1,023
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elchanan Orlansky was code 99213 (office e&m - established), 1,126 times for 245 patients. In total Elchanan Orlansky billed 2,691 services in 17 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,126 | 245 | $57.46 | $65K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 367 | 114 | $44.03 | $16K |
| 80307 Drug Tests | Office | 344 | 180 | $60.33 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 302 | 42 | $0.08 | $25.12 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 177 | 124 | $151.49 | $27K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 166 | 101 | $111.59 | $19K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 70 | 25 | $43.69 | $3,058 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 35 | 29 | $33.91 | $1,187 |
| 20552 Musculoskeletal | Office | 33 | 29 | $32.33 | $1,067 |
| 20610 Joint Injection | Office | 30 | 15 | $44.57 | $1,337 |
| 99214 Office E&M - Established | Office | 29 | 27 | $84.20 | $2,442 |
By year: 2022 $222K for 3,682 services; 2023 $165K for 2,868 services; 2024 $156K for 2,691 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 344 | 180 | $60.33 | $21K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 177 | 124 | $151.49 | $27K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 166 | 101 | $111.59 | $19K |
Medicare prescription drug claims, 2024
In 2024, the drug Elchanan Orlansky prescribed most often to Medicare patients was Oxycodone Hcl, with 1,871 prescriptions and refills. In total Elchanan Orlansky wrote 10,720 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,871 | 1,872 | 352 | $30K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,097 | 1,098 | 208 | $29K |
| Lidocaine Generic | 701 | 756 | 194 | $55K |
| Cyclobenzaprine Hcl Generic | 695 | 726 | 161 | $51K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 681 | 681 | 154 | $17K |
| Gabapentin Generic | 650 | 739 | 164 | $8,965 |
| Tizanidine Hcl Generic | 395 | 423 | 103 | $3,123 |
| Morphine Sulfate Er Morphine Sulfate | 361 | 361 | 74 | $6,686 |
| Diclofenac Sodium Generic | 320 | 328 | 93 | $12K |
| Pregabalin Generic | 280 | 299 | 66 | $5,562 |
| Methocarbamol Generic | 277 | 299 | 70 | $3,693 |
| Celecoxib Generic | 259 | 267 | 65 | $6,054 |
| Diazepam Generic | 215 | 215 | 76 | $638 |
| Tramadol Hcl Generic | 198 | 198 | 52 | $2,216 |
| Oxycontin Oxycodone Hcl | 172 | 172 | 36 | $89K |
Brand drugs: 961 claims; generic drugs: 9,759 claims; opioid claims: 4,970.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elchanan Orlansky $1,023 ($1,023 in general payments such as food, travel and fees) from 9 companies. The largest payer was Collegium Pharmaceutical, Inc. with $325.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 33 | $325 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 38 | $315 |
| Pfizer Inc. PFE | 17 | $151 |
| Scilex Pharmaceuticals Inc. | 3 | $67.1 |
| Valinor Pharma, LLC | 3 | $51.36 |
| Abbvie Inc. ABBV | 2 | $44 |
| Axsome Therapeutics, Inc. AXSM | 1 | $32.21 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $23.28 |
| Orexo US, Inc. | 1 | $14.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.